Drug information for NIMOTOP

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 30MG Discontinued   NIMODIPINE Nimodipine BAYER PHARMS 18869
2006-01-31 Healthcare Professional Sheet

2006-01-30 Letter

2006-01-27 Label

2000-08-22 Letter

2000-08-22 Label

Drug Adverse Effects information for NIMOTOP

Role code Indications Reaction # Reports
C ANXIETY COELIAC DISEASE 2
C ANXIETY DIARRHOEA 2
C ASTHMA CEREBRAL HAEMORRHAGE 1
C ASTHMA CEREBROVASCULAR ACCIDENT 1
C ASTHMA CONFUSIONAL STATE 1
C ASTHMA DISORIENTATION 1
C ASTHMA HAEMORRHAGIC TRANSFORMATION STROKE 1
C ASTHMA IMMOBILE 1
C DEPRESSION COELIAC DISEASE 2
C DEPRESSION DIARRHOEA 2
C GASTRITIS EMBOLISM 1
C GASTRITIS HAEMATOMA 1
C GASTRITIS HEMIPLEGIA 1
C GASTRITIS UNDERDOSE 1
C HYPERSENSITIVITY COELIAC DISEASE 2
C HYPERSENSITIVITY DIARRHOEA 2
C HYPERTENSION CEREBRAL HAEMORRHAGE 1
C HYPERTENSION CEREBROVASCULAR ACCIDENT 1
C HYPERTENSION COELIAC DISEASE 4
C HYPERTENSION CONFUSIONAL STATE 1
C HYPERTENSION DIARRHOEA 4
C HYPERTENSION DISORIENTATION 1
C HYPERTENSION HAEMORRHAGIC TRANSFORMATION STROKE 1
C HYPERTENSION IMMOBILE 1
C PARKINSON'S DISEASE COELIAC DISEASE 8
C PARKINSON'S DISEASE DIARRHOEA 8
C PRODUCT USED FOR UNKNOWN INDICATION CEREBRAL HAEMORRHAGE 3
C PRODUCT USED FOR UNKNOWN INDICATION CEREBROVASCULAR ACCIDENT 3
C PRODUCT USED FOR UNKNOWN INDICATION CONFUSIONAL STATE 3
C PRODUCT USED FOR UNKNOWN INDICATION DISORIENTATION 3
C PRODUCT USED FOR UNKNOWN INDICATION HAEMORRHAGIC TRANSFORMATION STROKE 3
C PRODUCT USED FOR UNKNOWN INDICATION IMMOBILE 3
C THROMBOSIS PROPHYLAXIS EMBOLISM 1
C THROMBOSIS PROPHYLAXIS HAEMATOMA 1
C THROMBOSIS PROPHYLAXIS HEMIPLEGIA 1
C THROMBOSIS PROPHYLAXIS UNDERDOSE 1
Ads by Google